WCM Investment Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.3M | Buy |
275,235
+17,133
| +7% | +$769K | 0.03% | 137 |
|
|
2025
Q1 | $9.06M | Sell |
258,102
-3,842
| -1% | -$135K | 0.02% | 147 |
|
|
2024
Q4 | $7.16M | Sell |
261,944
-1,735
| -0.7% | -$47.4K | 0.02% | 163 |
|
|
2024
Q3 | $6.58M | Buy |
263,679
+86,987
| +49% | +$2.17M | 0.01% | 160 |
|
|
2024
Q2 | $4.45M | Buy |
176,692
+2,766
| +2% | +$69.7K | 0.01% | 166 |
|
|
2024
Q1 | $5.38M | Sell |
173,926
-117,717
| -40% | -$3.64M | 0.01% | 157 |
|
|
2023
Q4 | $12.2M | Buy |
291,643
+7,156
| +3% | +$299K | 0.03% | 136 |
|
|
2023
Q3 | $7.5M | Buy |
284,487
+5,833
| +2% | +$154K | 0.02% | 140 |
|
|
2023
Q2 | $4.79M | Sell |
278,654
-93,934
| -25% | -$1.62M | 0.01% | 159 |
|
|
2023
Q1 | $6.18M | Buy |
372,588
+4,797
| +1% | +$79.5K | 0.02% | 149 |
|
|
2022
Q4 | $2.8M | Sell |
367,791
-4,641
| -1% | -$35.4K | 0.01% | 178 |
|
|
2022
Q3 | $3.8M | Buy |
372,432
+29,363
| +9% | +$300K | 0.01% | 151 |
|
|
2022
Q2 | $3.03M | Buy |
343,069
+212
| +0.1% | +$1.87K | 0.01% | 160 |
|
|
2022
Q1 | $3.48M | Buy |
342,857
+216,587
| +172% | +$2.2M | 0.01% | 154 |
|
|
2021
Q4 | $2.11M | Buy |
126,270
+60,766
| +93% | +$1.01M | ﹤0.01% | 166 |
|
|
2021
Q3 | $3.07M | Buy |
65,504
+482
| +0.7% | +$22.6K | 0.01% | 160 |
|
|
2021
Q2 | $3.96M | Sell |
65,022
-40,406
| -38% | -$2.46M | 0.01% | 143 |
|
|
2021
Q1 | $6.49M | Sell |
105,428
-36,421
| -26% | -$2.24M | 0.02% | 131 |
|
|
2020
Q4 | $10.1M | Buy |
141,849
+36,053
| +34% | +$2.56M | 0.03% | 111 |
|
|
2020
Q3 | $3.97M | Buy |
105,796
+6,523
| +7% | +$245K | 0.01% | 143 |
|
|
2020
Q2 | $3.24M | Buy |
99,273
+33,050
| +50% | +$1.08M | 0.01% | 145 |
|
|
2020
Q1 | $1.92M | Buy |
+66,223
| New | +$1.92M | 0.01% | 151 |
|